Mechanism of the interaction between the intrinsically disordered C-terminus of the pro-apoptotic ARTS protein and the Bir3 domain of XIAP

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Reingewertz, Tali H ^a   Shalev, Deborah E ^a   Sukenik, Shahar ^a   Blatt, Ofrah ^a   Rotem Bamberger, Shahar ^a   Lebendiker, Mario ^a   Larisch, Sarit ^b   Friedler, Assaf ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS RELATED PROTEIN IN THE TGF BETA SIGNALING PATHWAY; DIMER; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; ALANINE; PEPTIDE; SEPTIN;

ARTICLE; BIR3 DOMAIN; C TERMINAL DOMAIN; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; FLUORESCENCE SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; OXIDATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; QUANTITATIVE ANALYSIS; AMINO ACID SEQUENCE; APOPTOSIS; CHEMISTRY; CIRCULAR DICHROISM; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN ANALYSIS; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION;

INTRACISTERNAL A-PARTICLES;

ALANINE; AMINO ACID SEQUENCE; APOPTOSIS; CIRCULAR DICHROISM; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEPTINS; STRUCTURE-ACTIVITY RELATIONSHIP; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 80052944668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024655     Document Type: Article

References (51)

1. Thompson CB, (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
2. Wright PE, Dyson HJ, (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol 293: 321-331.
3. Uversky VN, Oldfield CJ, Dunker AK, (2005) Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit 18: 343-384.
4. Fink AL, (2005) Natively unfolded proteins. Curr Opin Struct Biol 15: 35-41.
5. Fuxreiter M, Simon I, Friedrich P, Tompa P, (2004) Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. J Mol Biol 338: 1015-1026.
6. Bussell R Jr, Eliezer D, (2001) Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein. J Biol Chem 276: 45996-46003.
7. Tompa P, (2005) The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett 579: 3346-3354.
8. Dunker AK, Cortese MS, Romero P, Iakoucheva LM, Uversky VN, (2005) Flexible nets. The roles of intrinsic disorder in protein interaction networks. Febs J 272: 5129-5148.
9. Uversky VN, Oldfield CJ, Dunker AK, (2008) Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu Rev Biophys 37: 215-246.
10. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK, (2002) Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323: 573-584.
11. Xie H, Vucetic S, Iakoucheva LM, Oldfield CJ, Dunker AK, et al. (2007) Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins. J Proteome Res 6: 1917-1932.
12. Lee GM, Craik CS, (2009) Trapping moving targets with small molecules. Science 324: 213-215.
13. Uversky VN, (2010) Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept. Expert Rev Proteomics 7: 543-564.
14. Metallo SJ, (2010) Intrinsically disordered proteins are potential drug targets. Curr Opin Chem Biol 14: 481-488.
15. Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van YY, et al. (2006) Rational drug design via intrinsically disordered protein. Trends Biotechnol 24: 435-442.
16. Larisch S, Yi Y, Lotan R, Kerner H, Eimerl S, et al. (2000) A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nat Cell Biol 2: 915-921.
17. Larisch-Bloch S, Danielpour D, Roche NS, Lotan R, Hsing AY, et al. (2000) Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells. Cell Growth Differ 11: 1-10.
18. Elhasid R, Sahar D, Merling A, Zivony Y, Rotem A, et al. (2004) Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients. Oncogene 23: 5468-5475.
19. Gottfried Y, Rotem A, Lotan R, Steller H, Larisch S, (2004) The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. Embo J 23: 1627-1635.
20. Bornstein B, Gottfried Y, Edison N, Shekhtman A, Lev T, et al. ARTS binds to a distinct domain in XIAP-BIR3 and promotes apoptosis by a mechanism that is different from other IAP-antagonists. Apoptosis Accepted for publication.
21. Garrison JB, Correa RG, Gerlic M, Yip KW, Krieg A, et al. (2011) ARTS and Siah collaborate in a pathway for XIAP degradation. Mol Cell 41: 107-116.
22. Shi Y, (2002) A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ 9: 93-95.
23. Srinivasula SM, Ashwell JD, (2008) IAPs: what's in a name? Mol Cell 30: 123-135.
24. Eckelman BP, Salvesen GS, (2006) The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 281: 3254-3260.
25. Hunter AM, LaCasse EC, Korneluk RG, (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543-1568.
26. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, et al. (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803.
27. Garcia-Fernandez M, Kissel H, Brown S, Gorenc T, Schile AJ, et al. (2010) Sept4/ARTS is required for stem cell apoptosis and tumor suppression. Genes Dev 24: 2282-2293.
28. Du C, Fang M, Li Y, Li L, Wang X, (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42.
29. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, et al. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53.
30. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, et al. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8: 613-621.
31. van Loo G, van Gurp M, Depuydt B, Srinivasula SM, Rodriguez I, et al. (2002) The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 9: 20-26.
32. Martins LM, (2002) The serine protease Omi/HtrA2: a second mammalian protein with a Reaper-like function. Cell Death Differ 9: 699-701.
33. Chai J, Du C, Wu JW, Kyin S, Wang X, et al. (2000) Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406: 855-862.
34. Macara IG, Baldarelli R, Field CM, Glotzer M, Hayashi Y, et al. (2002) Mammalian septins nomenclature. Mol Biol Cell 13: 4111-4113.
35. Garcia W, de Araujo AP, Neto Mde O, Ballestero MR, Polikarpov I, et al. (2006) Dissection of a human septin: definition and characterization of distinct domains within human SEPT4. Biochemistry 45: 13918-13931.
36. Mandel-Gutfreund Y, Kosti I, Larisch S, ARTS, the Unusual Septin: Structural and Functional aspects. Biological Chemistry Accepted for publication.
37. Whitmore L, Wallace BA, (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32: W668-673.
38. Whitmore L, Wallace BA, (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89: 392-400.
39. Dyson HJ, Wright PE, (2002) Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol 12: 54-60.
40. Uversky VN, (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11: 739-756.
41. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, et al. (2008) IAP-targeted therapies for cancer. Oncogene 27: 6252-6275.
42. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, et al. (2010) IAP regulation of metastasis. Cancer Cell 17: 53-64.
43. Chen DJ, Huerta S, (2009) Smac mimetics as new cancer therapeutics. Anticancer Drugs 20: 646-658.
44. Katz C, Benyamini H, Rotem S, Lebendiker M, Danieli T, et al. (2008) Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2. Proc Natl Acad Sci U S A 105: 12277-12282.
45. Hayouka Z, Rosenbluh J, Levin A, Loya S, Lebendiker M, et al. (2007) Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc Natl Acad Sci U S A 104: 8316-8321.
46. Tam JP, Wu CR, Liu W, Zhang JW, (1991) Disulfide Bond Formation in Peptides by Dimethyl Sulfoxide. Scope and Applications. J Am Chem Soc 113: 6657-6662.
47. Bax A, Davis DG, (1985) Mlev-17-Based Two-Dimensional Homonuclear Magnetization Transfer Spectroscopy. Journal of Magnetic Resonance 65: 355-360.
48. Aue WP, Bartholdi E, Ernst RR, (1976) 2-Dimensional Spectroscopy- Application to Nuclear Magnetic-Resonance. Journal of Chemical Physics 64: 2229-2246.
49. Kumar A, Wagner G, Ernst RR, Wuthrich K, (1980) Studies of J-connectives and selective 1H-1H Overhauser effects in H2O solutions of biological macromolecules by two-dimensional NMR experiments. Biochem Biophys Res Commun 96: 1156-1163.
50. Wüthrich K, (1986) NMR of Proteins and Nucleic Acids; In: Sons JW, editors. New York.
51. Ferron F, Longhi S, Canard B, Karlin D, (2006) A practical overview of protein disorder prediction methods. Proteins 65: 1-14.